Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
54.83 USD | +1.71% | -2.80% | -12.41% |
Apr. 18 | Citigroup Adjusts CRISPR Therapeutics' Price Target to $89 From $88, Keeps Buy Rating | MT |
Apr. 17 | Crispr Therapeutics Insider Sold Shares Worth $1,173,232, According to a Recent SEC Filing | MT |